Researchers Submit Patent Application, 'Inhibitors Of Histone Deacetylase-3 Useful For The Treatment Of Cancer, Inflammation, Neurodegeneration Diseases And Diabetes', for Approval (USPTO 20220177465)

Source :: Cancer Weekly. June 28, 2022, 489
Publication Year :: 2022
Abstract: 2022 JUN 28 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors KELLY, Joseph [...]

Subjects :: Merck Sharp & Dohme Corp. -- Intellectual property
Diabetes therapy -- Intellectual property
Inflammation
Antiviral agents
Anti-HIV agents
Cancer -- Care and treatment
Darunavir
Atazanavir -- Intellectual property
Type 2 diabetes
Pharmaceutical industry -- Intellectual property
Business
Health
Health care industry

Tools